iN-VITRO INTERACTION STUDIES OF VERAPAMIL WITH FLUOROQUINOLONES USING FIRST ORDER DERIVATIVE UV SPECTROPHOTOMETRY AND RP-HPLC

Verapamil, a calcium channel blocker, is classified as a class IV anti-arrhythmic agent. It is used in the treatment of hypertension, as an important therapeutic agent for angina pectoris, ischemic heart disease, hypertension and hypertrophic cardiomyopathy. Many in-vivo studies have been carried ou...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: SULTANA,NAJMA, SAEED ARAYNE,MUHAMMAD, WAHEED,ABDUL
Lenguaje:English
Publicado: Sociedad Chilena de Química 2011
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072011000400005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0717-97072011000400005
record_format dspace
spelling oai:scielo:S0717-970720110004000052012-03-06iN-VITRO INTERACTION STUDIES OF VERAPAMIL WITH FLUOROQUINOLONES USING FIRST ORDER DERIVATIVE UV SPECTROPHOTOMETRY AND RP-HPLCSULTANA,NAJMASAEED ARAYNE,MUHAMMADWAHEED,ABDUL Verapamil anti-arrhythmic agent angina pectoris hypertrophic cardiomyopathy fluoroquinolone HPLC and UV spectrophotometry Verapamil, a calcium channel blocker, is classified as a class IV anti-arrhythmic agent. It is used in the treatment of hypertension, as an important therapeutic agent for angina pectoris, ischemic heart disease, hypertension and hypertrophic cardiomyopathy. Many in-vivo studies have been carried out to find out the effects on concurrent use of calcium channel blocker with various groups of drugs. In the present paper an in-vitro approach was adapted to study the interaction of verapamil with commonly administered fluoroquinolones i.e. ciprofloxacin, levofloxacin, norfloxacin and sparfloxacin. The interaction studies were carried out in different simulated body fluids pH ranges from 1-9 at 37 ºC. To perform these studies first-derivative UV spectrophotometric (using zero-crossing technique) and simultaneous RP-HPLC methods were developed and validated. HPLC analysis was conducted on Shim-pack CLC-ODS (6.0 X 150 mm) column. The mobile phase constituted of acetonitrile: water (45:55), whose pH was adjusted to 2.8 and pumped at a flow rate of 1.2 mL min-1 at 230 nm. The results obtained from both methodologies indicated that the availability of verapamil was not affected by simultaneous administration of fluoroquinolones. Hence the two drugs could be safely administered concomitantly.info:eu-repo/semantics/openAccessSociedad Chilena de QuímicaJournal of the Chilean Chemical Society v.56 n.4 20112011-12-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072011000400005en10.4067/S0717-97072011000400005
institution Scielo Chile
collection Scielo Chile
language English
topic Verapamil
anti-arrhythmic agent
angina pectoris
hypertrophic cardiomyopathy
fluoroquinolone
HPLC and UV spectrophotometry
spellingShingle Verapamil
anti-arrhythmic agent
angina pectoris
hypertrophic cardiomyopathy
fluoroquinolone
HPLC and UV spectrophotometry
SULTANA,NAJMA
SAEED ARAYNE,MUHAMMAD
WAHEED,ABDUL
iN-VITRO INTERACTION STUDIES OF VERAPAMIL WITH FLUOROQUINOLONES USING FIRST ORDER DERIVATIVE UV SPECTROPHOTOMETRY AND RP-HPLC
description Verapamil, a calcium channel blocker, is classified as a class IV anti-arrhythmic agent. It is used in the treatment of hypertension, as an important therapeutic agent for angina pectoris, ischemic heart disease, hypertension and hypertrophic cardiomyopathy. Many in-vivo studies have been carried out to find out the effects on concurrent use of calcium channel blocker with various groups of drugs. In the present paper an in-vitro approach was adapted to study the interaction of verapamil with commonly administered fluoroquinolones i.e. ciprofloxacin, levofloxacin, norfloxacin and sparfloxacin. The interaction studies were carried out in different simulated body fluids pH ranges from 1-9 at 37 ºC. To perform these studies first-derivative UV spectrophotometric (using zero-crossing technique) and simultaneous RP-HPLC methods were developed and validated. HPLC analysis was conducted on Shim-pack CLC-ODS (6.0 X 150 mm) column. The mobile phase constituted of acetonitrile: water (45:55), whose pH was adjusted to 2.8 and pumped at a flow rate of 1.2 mL min-1 at 230 nm. The results obtained from both methodologies indicated that the availability of verapamil was not affected by simultaneous administration of fluoroquinolones. Hence the two drugs could be safely administered concomitantly.
author SULTANA,NAJMA
SAEED ARAYNE,MUHAMMAD
WAHEED,ABDUL
author_facet SULTANA,NAJMA
SAEED ARAYNE,MUHAMMAD
WAHEED,ABDUL
author_sort SULTANA,NAJMA
title iN-VITRO INTERACTION STUDIES OF VERAPAMIL WITH FLUOROQUINOLONES USING FIRST ORDER DERIVATIVE UV SPECTROPHOTOMETRY AND RP-HPLC
title_short iN-VITRO INTERACTION STUDIES OF VERAPAMIL WITH FLUOROQUINOLONES USING FIRST ORDER DERIVATIVE UV SPECTROPHOTOMETRY AND RP-HPLC
title_full iN-VITRO INTERACTION STUDIES OF VERAPAMIL WITH FLUOROQUINOLONES USING FIRST ORDER DERIVATIVE UV SPECTROPHOTOMETRY AND RP-HPLC
title_fullStr iN-VITRO INTERACTION STUDIES OF VERAPAMIL WITH FLUOROQUINOLONES USING FIRST ORDER DERIVATIVE UV SPECTROPHOTOMETRY AND RP-HPLC
title_full_unstemmed iN-VITRO INTERACTION STUDIES OF VERAPAMIL WITH FLUOROQUINOLONES USING FIRST ORDER DERIVATIVE UV SPECTROPHOTOMETRY AND RP-HPLC
title_sort in-vitro interaction studies of verapamil with fluoroquinolones using first order derivative uv spectrophotometry and rp-hplc
publisher Sociedad Chilena de Química
publishDate 2011
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072011000400005
work_keys_str_mv AT sultananajma invitrointeractionstudiesofverapamilwithfluoroquinolonesusingfirstorderderivativeuvspectrophotometryandrphplc
AT saeedaraynemuhammad invitrointeractionstudiesofverapamilwithfluoroquinolonesusingfirstorderderivativeuvspectrophotometryandrphplc
AT waheedabdul invitrointeractionstudiesofverapamilwithfluoroquinolonesusingfirstorderderivativeuvspectrophotometryandrphplc
_version_ 1718445453913096192